Foreword
The fact that we are developing guidance centred on the ageing of individuals living with HIV is testament to the success and dedication of scientists, clinicians and patient advocates in getting HIV care to where it is today. Antiretroviral therapy has improved the survival, and thus life expectancy, of those that take it. However, it alone is not sufficient to ensure that all people living with HIV have the opportunity to age well. Barriers to successful ageing include uncontrolled medical comorbidities, frailty, adverse behavioural risk factors and psychosocial problems, including HIV-related stigma and negative socioeconomic circumstances.
Observational studies point to an excess of age-related comorbidities in people living with HIV, occurring in some circumstances at earlier ages than we might see in the general population. Frailty is one such problem, and it may help identify those who are most likely to need enhanced input from health, social and community services.
Frailty, alongside other age-related issues such as falls, mobility decline and cognitive impairment, may be less familiar to those working in HIV services compared to those of us who deal with older adults more regularly in our professional lives. HIV treatment and monitoring guidance is beginning to reflect these issues, yet the supporting ‘how to’ approach is lacking. HIV services have always been adaptable to the changing needs of their users, with some creating pathways or clinics dedicated to age-related issues where there is sufficient user demand or where those living with HIV fall between the gaps of existing frailty services.
There is no one-size-fits-all approach here, and a lack of HIV-specific tools and clinically applicable research means the evidence base is in its infancy. However, frailty has consequences and is potentially reversible, so early identification and intervention is key. Through this document, we have aimed to provide an accessible guide to support and empower those working in HIV to identify and manage individuals living with frailty and HIV. It is by no means exhaustive, but we have tried to signpost to other resources along the way, which you may wish to complement with the help of a friendly local geriatrician!

Senior Lecturer in Medicine and Frailty, Brighton and Sussex Medical School Honorary Consultant Geriatrician, Royal Sussex County Hospital, Brighton
Co-lead of the Brighton joint HIV-ageing ‘Silver’ Clinic
Advanced Clinical Practitioner in HIV and Sexual Health, Manchester University NHS Foundation Trust, Manchester
Acknowledgements
Dr Tom Levett, Consultant Geriatrician with a special interest in HIV and Ageing, University Hospitals Sussex NHS Foundation Trust, Brighton
Prof. Marta Boffito, HIV Consultant, Chelsea & Westminster Hospital NHS Foundation Trust, London
Dr Tristan Barber, HIV Consultant, Ian Charleson Day Centre, Royal Free London NHS Foundation Trust, London; Institute for Global Health, University College London, London
Darren Brown, HIV Specialist Physiotherapist, Chelsea & Westminster Hospital NHS Foundation Trust, Therapies Department, London
Jill Williams, Community HIV Clinics Nurse Specialist, Liverpool University Hospitals NHS Foundation Trust, Liverpool
Nicola Galbraith, HIV Standards Support Team Manager, Gilead Sciences
Philippa Pristerà, Patient Engagement Strategy Lead, Cuttsy+Cuttsy
Garry Brough, HIV Advocate, Lead for Peer Learning, Partnerships & Policy, Positively UK
Memory Sachikonye, HIV Advocate, UK-CAB Coordinator, HIV i-Base
Justine Mellor, Advanced Clinical Practitioner in HIV and Sexual Health, Manchester University NHS Foundation Trust
Breda Patterson, National Market Access Senior Manager HIV, Gilead Sciences Ltd
All rights reserved. This guide or any portion thereof may not be reproduced or used in any manner whatsoever without the express written permission of the publisher except for the use of brief quotations in a book review. The authors have asserted their moral right to be identified as authors of this work, in accordance with the Copyright, Designs and Patents Act 1998.
Copyright© 2023, Gilead Sciences Limited